According to Deloitte’s report “The Pharmaceutical Industry in Turkey and the World: Growth Prospects,” the money spent on drugs accounts for nearly one-third of the total health expenditure in Turkey. The country’s per capita pharmaceutical consumption is $140, according to the report, while this figure is $680 in the US, $378 in France, $301 in Germany and $257 in the UK. According to Güler Hülya Yılmaz, the head of Deloitte Turkey’s Health and Drug Industry division, per capita spending on pharmaceuticals is expected to rise in Turkey in the future in line with an aging population.
The Turkish pharmaceutical industry is ranked among the world’s top 15 markets, the report stated. Currently, 300 firms operate in the Turkish pharmaceutical sector, with 53 of them having their own production facilities, according to the report, while the pharmaceutical market comprises 23,000 pharmacies along with approximately 500 pharmaceutical warehouses.
The market for prescription drugs was estimated to have grown nearly twofold between 2003 and 2008, increasing from TL 6.2 billion to TL 12.1 billion.
